Vault-13

Integral Health Asset Management, LLC

New York, NY · CIK 1773206 · 13F filing filed 2023-08-11

SEC-registered investment adviser since 2020 · limited liability company

As an employer

$762.0m reported value +58.3% vs Q1 2023
70positions
36.2%in top 10
30 new 25 added 12 reduced 27 sold out vs Q1 2023

Options: 2 call positions ($5.1m notional), 1 put positions ($40.5m notional) – listed below, not included above.

Holdings, Q2 2023

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 THE CIGNA GROUP COM CI CI 180,000 $50.5m6.63% 6.63% NewShares held: Q3 2022 0, Q4 2022 45.0k, Q1 2023 0, Q2 2023 180.0k
2 ZIMMER BIOMET HOLDINGS INC COM ZBH ZBH 300,000 $43.7m5.73% 5.73% NewShares held: Q3 2022 0, Q4 2022 65.0k, Q1 2023 0, Q2 2023 300.0k
3 INSPIRE MED SYS INC COM INSP INSP 103,000 $33.4m4.39% 4.39% AddedShares held: Q3 2022 40.0k, Q4 2022 60.0k, Q1 2023 80.0k, Q2 2023 103.0k +23.0k +23,000 28.8%
4 MCKESSON CORP COM MCK MCK 72,000 $30.8m4.04% 4.04% NewShares held: Q3 2022 30.0k, Q4 2022 0, Q1 2023 0, Q2 2023 72.0k
5 BOSTON SCIENTIFIC CORP COM BSX BSX 466,000 $25.2m3.31% 3.31% AddedShares held: Q3 2022 350.0k, Q4 2022 0, Q1 2023 152.0k, Q2 2023 466.0k +314.0k +314,000 206.6%
6 CYTOKINETICS INC COM NEW CYTK CYTK 650,000 $21.2m2.78% 2.78% AddedShares held: Q3 2022 350.0k, Q4 2022 400.0k, Q1 2023 600.0k, Q2 2023 650.0k +50.0k +50,000 8.3%
7 COOPER COS INC COM NEW COM NEW 52,000 $19.9m2.62% 2.62% AddedShares held: Q3 2022 0, Q4 2022 15.0k, Q1 2023 40.0k, Q2 2023 52.0k +12.0k +12,000 30.0%
8 TENET HEALTHCARE CORP COM NEW THC THC 232,000 $18.9m2.48% 2.48% NewShares held: Q3 2022 130.0k, Q4 2022 0, Q1 2023 0, Q2 2023 232.0k
9 REVVITY INC COM RVTY RVTY 140,000 $16.6m2.18% 2.18% AddedShares held: Q3 2022 0, Q4 2022 0, Q1 2023 85.0k, Q2 2023 140.0k +55.0k +55,000 64.7%
10 ARGENX SE SPONSORED ADR ARGX ARGX 40,000 $15.6m2.05% 2.05% AddedShares held: Q3 2022 0, Q4 2022 10.0k, Q1 2023 12.0k, Q2 2023 40.0k +28.0k +28,000 233.3%
11 MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD MLTX MLTX 300,000 $15.3m2.01% 2.01% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 300.0k
12 ENCOMPASS HEALTH CORP COM EHC EHC 220,000 $14.9m1.95% 1.95% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 220.0k
13 GUARDANT HEALTH INC COM GH GH 412,000 $14.7m1.94% 1.94% AddedShares held: Q3 2022 450.0k, Q4 2022 475.0k, Q1 2023 350.0k, Q2 2023 412.0k +62.0k +62,000 17.7%
14 HOLOGIC INC COM HOLX HOLX 175,000 $14.2m1.86% 1.86% AddedShares held: Q3 2022 0, Q4 2022 0, Q1 2023 75.0k, Q2 2023 175.0k +100.0k +100,000 133.3%
15 ELI LILLY & CO COM LLY LLY 30,000 $14.1m1.85% 1.85% NewShares held: Q3 2022 25.0k, Q4 2022 0, Q1 2023 0, Q2 2023 30.0k
16 CENTENE CORP DEL COM CNC CNC 200,000 $13.5m1.77% 1.77% NewShares held: Q3 2022 225.0k, Q4 2022 100.0k, Q1 2023 0, Q2 2023 200.0k
17 ABBVIE INC COM ABBV ABBV 100,000 $13.5m1.77% 1.77% AddedShares held: Q3 2022 0, Q4 2022 50.0k, Q1 2023 81.0k, Q2 2023 100.0k +19.0k +19,000 23.5%
18 ELEVANCE HEALTH INC COM ELV ELV 30,000 $13.3m1.75% 1.75% ReducedShares held: Q3 2022 40.0k, Q4 2022 25.0k, Q1 2023 51.0k, Q2 2023 30.0k -21.0k -21,000 -41.2%
19 SCHRODINGER INC COM SDGR SDGR 265,000 $13.2m1.74% 1.74% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 265.0k
20 ZENTALIS PHARMACEUTICALS INC COM ZNTL ZNTL 450,000 $12.7m1.67% 1.67% ReducedShares held: Q3 2022 550.0k, Q4 2022 750.0k, Q1 2023 600.0k, Q2 2023 450.0k -150.0k -150,000 -25.0%
21 GSK PLC SPONSORED ADR GSK GSK 350,000 $12.5m1.64% 1.64% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 350.0k
22 INTUITIVE SURGICAL INC COM NEW ISRG ISRG 36,000 $12.3m1.62% 1.62% NewShares held: Q3 2022 0, Q4 2022 44.0k, Q1 2023 0, Q2 2023 36.0k
23 REATA PHARMACEUTICALS INC CL A RETA RETA 120,000 $12.2m1.61% 1.61% AddedShares held: Q3 2022 0, Q4 2022 85.0k, Q1 2023 71.0k, Q2 2023 120.0k +49.0k +49,000 69.0%
24 HCA HEALTHCARE INC COM HCA HCA 40,000 $12.1m1.59% 1.59% ReducedShares held: Q3 2022 0, Q4 2022 43.0k, Q1 2023 45.0k, Q2 2023 40.0k -5.0k -5,000 -11.1%
25 DANAHER CORPORATION COM DHR DHR 50,000 $12.0m1.57% 1.57% NewShares held: Q3 2022 30.0k, Q4 2022 0, Q1 2023 0, Q2 2023 50.0k
26 JOHNSON & JOHNSON COM JNJ JNJ 72,000 $11.9m1.56% 1.56% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 72.0k
27 VIKING THERAPEUTICS INC COM VKTX VKTX 730,000 $11.8m1.55% 1.55% AddedShares held: Q3 2022 0, Q4 2022 600.0k, Q1 2023 727.1k, Q2 2023 730.0k +2.9k +2,900 0.4%
28 VENTYX BIOSCIENCES INC COM VTYX VTYX 350,000 $11.5m1.51% 1.51% AddedShares held: Q3 2022 100.0k, Q4 2022 210.0k, Q1 2023 290.0k, Q2 2023 350.0k +60.0k +60,000 20.7%
29 SURGERY PARTNERS INC COM SGRY SGRY 250,000 $11.2m1.48% 1.48% AddedShares held: Q3 2022 0, Q4 2022 0, Q1 2023 122.0k, Q2 2023 250.0k +128.0k +128,000 104.9%
30 NOVARTIS AG SPONSORED ADR NVS NVS 103,000 $10.4m1.36% 1.36% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 103.0k
31 REPLIMUNE GROUP INC COM REPL REPL 445,000 $10.3m1.36% 1.36% AddedShares held: Q3 2022 200.0k, Q4 2022 220.0k, Q1 2023 395.0k, Q2 2023 445.0k +50.0k +50,000 12.7%
32 PENUMBRA INC COM PEN PEN 30,000 $10.3m1.35% 1.35% ReducedShares held: Q3 2022 0, Q4 2022 30.0k, Q1 2023 35.0k, Q2 2023 30.0k -5.0k -5,000 -14.3%
33 ALNYLAM PHARMACEUTICALS INC COM ALNY ALNY 52,000 $9.9m1.30% 1.30% AddedShares held: Q3 2022 70.0k, Q4 2022 35.0k, Q1 2023 20.0k, Q2 2023 52.0k +32.0k +32,000 160.0%
34 REVOLUTION MEDICINES INC COM RVMD RVMD 356,000 $9.5m1.25% 1.25% AddedShares held: Q3 2022 0, Q4 2022 0, Q1 2023 345.0k, Q2 2023 356.0k +11.0k +11,000 3.2%
35 INARI MED INC COM NARI NARI 155,000 $9.0m1.18% 1.18% AddedShares held: Q3 2022 0, Q4 2022 0, Q1 2023 100.0k, Q2 2023 155.0k +55.0k +55,000 55.0%
36 INTRA-CELLULAR THERAPIES INC COM ITCI ITCI 142,000 $9.0m1.18% 1.18% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 142.0k
37 ALKERMES PLC SHS ALKS ALKS 284,000 $8.9m1.17% 1.17% AddedShares held: Q3 2022 200.0k, Q4 2022 0, Q1 2023 179.0k, Q2 2023 284.0k +105.0k +105,000 58.7%
38 RELAY THERAPEUTICS INC COM RLAY RLAY 700,000 $8.8m1.15% 1.15% ReducedShares held: Q3 2022 600.0k, Q4 2022 625.0k, Q1 2023 770.0k, Q2 2023 700.0k -70.0k -70,000 -9.1%
39 INTELLIA THERAPEUTICS INC COM NTLA NTLA 206,000 $8.4m1.10% 1.10% NewShares held: Q3 2022 125.0k, Q4 2022 150.0k, Q1 2023 0, Q2 2023 206.0k
40 EXACT SCIENCES CORP COM EXAS EXAS 88,000 $8.3m1.08% 1.08% ReducedShares held: Q3 2022 150.0k, Q4 2022 275.0k, Q1 2023 162.0k, Q2 2023 88.0k -74.0k -74,000 -45.7%
41 TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS SPONSORED ADS 1,000,000 $7.5m0.99% 0.99% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 1.0m
42 KRYSTAL BIOTECH INC COM KRYS KRYS 62,000 $7.3m0.96% 0.96% ReducedShares held: Q3 2022 90.0k, Q4 2022 115.0k, Q1 2023 85.0k, Q2 2023 62.0k -23.0k -23,000 -27.1%
43 PTC THERAPEUTICS INC COM PTCT PTCT 174,000 $7.1m0.93% 0.93% ReducedShares held: Q3 2022 163.0k, Q4 2022 100.0k, Q1 2023 178.0k, Q2 2023 174.0k -4.0k -4,000 -2.2%
44 LIFESTANCE HEALTH GROUP INC COM LFST LFST 773,000 $7.1m0.93% 0.93% AddedShares held: Q3 2022 525.0k, Q4 2022 0, Q1 2023 709.0k, Q2 2023 773.0k +64.0k +64,000 9.0%
45 MEDTRONIC PLC SHS MDT MDT 80,000 $7.0m0.92% 0.92% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 80.0k
46 APELLIS PHARMACEUTICALS INC COM APLS APLS 72,000 $6.6m0.86% 0.86% NewShares held: Q3 2022 70.0k, Q4 2022 0, Q1 2023 0, Q2 2023 72.0k
47 REVANCE THERAPEUTICS INC COM RVNC RVNC 250,000 $6.3m0.83% 0.83% UnchangedShares held: Q3 2022 150.0k, Q4 2022 240.0k, Q1 2023 250.0k, Q2 2023 250.0k
48 TG THERAPEUTICS INC COM TGTX TGTX 250,000 $6.2m0.81% 0.81% NewShares held: Q3 2022 0, Q4 2022 150.0k, Q1 2023 0, Q2 2023 250.0k
49 SI-BONE INC COM SIBN SIBN 227,000 $6.1m0.80% 0.80% NewShares held: Q3 2022 200.0k, Q4 2022 0, Q1 2023 0, Q2 2023 227.0k
50 CRISPR THERAPEUTICS AG NAMEN AKT CRSP CRSP 100,000 $5.6m0.74% 0.74% UnchangedShares held: Q3 2022 220.0k, Q4 2022 0, Q1 2023 100.0k, Q2 2023 100.0k
51 PRIVIA HEALTH GROUP INC COM PRVA PRVA 200,000 $5.2m0.69% 0.69% NewShares held: Q3 2022 0, Q4 2022 130.0k, Q1 2023 0, Q2 2023 200.0k
52 ENVISTA HOLDINGS CORPORATION COM NVST NVST 150,000 $5.1m0.67% 0.67% ReducedShares held: Q3 2022 440.0k, Q4 2022 100.0k, Q1 2023 152.0k, Q2 2023 150.0k -2.0k -2,000 -1.3%
53 TELADOC HEALTH INC COM TDOC TDOC 200,000 $5.1m0.66% 0.66% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 200.0k
54 CENCORA INC COM COR COR 26,000 $5.0m0.66% 0.66% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 26.0k
55 AMICUS THERAPEUTICS INC COM FOLD FOLD 387,000 $4.9m0.64% 0.64% AddedShares held: Q3 2022 130.0k, Q4 2022 327.0k, Q1 2023 305.0k, Q2 2023 387.0k +82.0k +82,000 26.9%
56 LONGBOARD PHARMACEUTICALS IN COM COM 598,000 $4.4m0.58% 0.58% AddedShares held: Q3 2022 110.0k, Q4 2022 243.0k, Q1 2023 582.0k, Q2 2023 598.0k +16.0k +16,000 2.8%
57 CROSS CTRY HEALTHCARE INC COM CCRN CCRN 155,000 $4.4m0.57% 0.57% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 155.0k
58 BIOMARIN PHARMACEUTICAL INC COM BMRN BMRN 50,000 $4.3m0.57% 0.57% ReducedShares held: Q3 2022 107.0k, Q4 2022 170.0k, Q1 2023 100.0k, Q2 2023 50.0k -50.0k -50,000 -50.0%
59 DENTSPLY SIRONA INC COM XRAY XRAY 100,000 $4.0m0.53% 0.53% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 100.0k
60 BIONTECH SE SPONSORED ADS BNTX BNTX 36,000 $3.9m0.51% 0.51% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 36.0k
61 SAGE THERAPEUTICS INC COM SAGE SAGE 80,000 $3.8m0.49% 0.49% ReducedShares held: Q3 2022 357.0k, Q4 2022 360.0k, Q1 2023 245.0k, Q2 2023 80.0k -165.0k -165,000 -67.3%
62 PROTHENA CORP PLC SHS PRTA PRTA 52,000 $3.6m0.47% 0.47% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 52.0k
63 AKERO THERAPEUTICS INC COM AKRO AKRO 70,000 $3.3m0.43% 0.43% UnchangedShares held: Q3 2022 230.0k, Q4 2022 70.0k, Q1 2023 70.0k, Q2 2023 70.0k
64 SUPERNUS PHARMACEUTICALS INC COM SUPN SUPN 75,000 $2.3m0.30% 0.30% ReducedShares held: Q3 2022 0, Q4 2022 40.0k, Q1 2023 125.0k, Q2 2023 75.0k -50.0k -50,000 -40.0%
65 KEROS THERAPEUTICS INC COM KROS KROS 52,000 $2.1m0.27% 0.27% AddedShares held: Q3 2022 0, Q4 2022 60.0k, Q1 2023 50.0k, Q2 2023 52.0k +2.0k +2,000 4.0%
66 PROTAGONIST THERAPEUTICS INC COM PTGX PTGX 75,000 $2.1m0.27% 0.27% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 75.0k
67 ALLOGENE THERAPEUTICS INC COM ALLO ALLO 412,000 $2.0m0.27% 0.27% AddedShares held: Q3 2022 0, Q4 2022 0, Q1 2023 405.0k, Q2 2023 412.0k +7.0k +7,000 1.7%
68 ELANCO ANIMAL HEALTH INC COM ELAN ELAN 200,000 $2.0m0.26% 0.26% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 200.0k
69 TERNS PHARMACEUTICALS INC COM COM 180,000 $1.6m0.21% 0.21% AddedShares held: Q3 2022 0, Q4 2022 0, Q1 2023 100.0k, Q2 2023 180.0k +80.0k +80,000 80.0%
70 DYNE THERAPEUTICS INC COM DYN DYN 62,000 $697.5k0.09% 0.09% AddedShares held: Q3 2022 0, Q4 2022 0, Q1 2023 57.0k, Q2 2023 62.0k +5.0k +5,000 8.8%

Sold out since Q1 2023

SecurityTickerShares held beforeValue then
STRYKER CORPORATION SYK SYK 50,000 $14.3m50.0k shares
TELEFLEX INCORPORATED TFX TFX 46,000 $11.7m46.0k shares
CARDINAL HEALTH INC CAH CAH 152,000 $11.5m152.0k shares
BIOGEN INC BIIB BIIB 40,000 $11.1m40.0k shares
UNIQURE NV QURE QURE 500,000 $10.1m500.0k shares
IDEXX LABS INC IDXX IDXX 20,000 $10.0m20.0k shares
HUMANA INC HUM HUM 20,000 $9.7m20.0k shares
MERCK & CO INC MRK MRK 90,000 $9.6m90.0k shares
BAXTER INTL INC BAX BAX 200,000 $8.1m200.0k shares
ALIGN TECHNOLOGY INC ALGN ALGN 22,000 $7.4m22.0k shares
MODERNA INC MRNA MRNA 35,000 $5.4m35.0k shares
AGIOS PHARMACEUTICALS INC AGIO AGIO 213,000 $4.9m213.0k shares
LABORATORY CORP AMER HLDGS 20,000 $4.6m20.0k shares
ACADIA HEALTHCARE COMPANY IN ACHC ACHC 61,000 $4.4m61.0k shares
NATERA INC NTRA NTRA 75,000 $4.2m75.0k shares
IRHYTHM TECHNOLOGIES INC IRTC IRTC 30,000 $3.7m30.0k shares
CHINOOK THERAPEUTICS INC ADRO ADRO 152,000 $3.5m152.0k shares
CATALENT INC CTLT CTLT 50,000 $3.3m50.0k shares
PROMETHEUS BIOSCIENCES INC 30,000 $3.2m30.0k shares
OPTION CARE HEALTH INC OPCH OPCH 101,000 $3.2m101.0k shares
REGENERON PHARMACEUTICALS REGN REGN 3,000 $2.5m3.0k shares
ITEOS THERAPEUTICS INC ITOS ITOS 180,000 $2.4m180.0k shares
THE BEAUTY HEALTH COMPANY 152,000 $1.9m152.0k shares
FIBROGEN INC 102,000 $1.9m102.0k shares
ACLARIS THERAPEUTICS INC ACRS ACRS 225,000 $1.8m225.0k shares

Options (notional value)

UnderlyingTickerTypeShares controlled NotionalChange
NOVO-NORDISK A S NVO · Put NVOPut 250,000 $40.5m250.0k shares New
WALGREENS BOOTS ALLIANCE INC WBA · Call WBACall 100,000 $2.8m100.0k shares New
UNIQURE NV QURE · Call QURECall 200,000 $2.3m200.0k shares New